Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 13,090,300 | 12,509,900 | 11,558,800 | 10,393,100 | 9,911,600 |
| Cost of Goods | 7,561,200 | 7,214,400 | 6,764,800 | 6,131,600 | 6,013,800 |
| Gross Profit | 5,529,100 | 5,295,500 | 4,794,000 | 4,261,500 | 3,897,800 |
| Operating Expenses | 3,919,700 | 3,813,800 | 3,544,000 | 3,074,000 | 2,896,500 |
| Operating Income | 1,609,600 | 1,482,100 | 1,250,800 | 1,188,100 | 1,002,100 |
| Other Income | -290,100 | -212,700 | -118,000 | -100,400 | -121,700 |
| Pre-tax Income | 1,319,500 | 1,269,400 | 1,132,800 | 1,087,700 | 880,400 |
| Income Tax | 40,400 | 11,000 | 109,400 | 101,600 | 57,200 |
| Net Income Continuous | 1,279,100 | 1,258,400 | 1,023,400 | 986,100 | 823,200 |
| Net Income Discontinuous | -5,800 | -80,500 | 306,500 | 49,500 | 27,100 |
| Net Income | $1,273,300 | $1,177,900 | $1,329,900 | $1,035,600 | $850,300 |
| EPS Basic Total Ops | 3.53 | 3.24 | 3.49 | 2.57 | 2.06 |
| EPS Basic Continuous Ops | 3.55 | 3.46 | 2.69 | 2.45 | 2.00 |
| EPS Basic Discontinuous Ops | -0.02 | -0.22 | 0.80 | 0.12 | 0.07 |
| EPS Diluted Total Ops | 3.48 | 3.21 | 3.46 | 2.53 | 2.01 |
| EPS Diluted Continuous Ops | 3.50 | 3.43 | 2.66 | 2.41 | 1.95 |
| EPS Diluted Discontinuous Ops | -0.02 | -0.22 | 0.80 | 0.12 | 0.06 |
| EBITDA(a) | $2,609,500 | $2,465,802 | $2,110,400 | $1,927,800 | $1,765,000 |